Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01019057 · ClinicalTrials.gov registry record

An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)

A clinical trial of Degenerative Disc Disease, sponsored by NuVasive.

Completed
Registry status
77
Enrollment target
8
Study locations

NCT01019057: Completed study of Degenerative Disc Disease, sponsored by NuVasive.

NCT01019057 is a study of Degenerative Disc Disease that has completed, run by NuVasive. The registered enrollment target is 77 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (54% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01019057, a study of Degenerative Disc Disease, has completed, sponsored by NuVasive.

COMPLETED
Registry status
77 participants
Enrollment target
8
Study locations

Study Summary

Patients diagnosed with single-level degenerative disc disease (DDD) of the lumbar spine undergo a posterior decompression followed by a fusion complete with a spinous process plate, graft, and a biologic.

Conditions Studied

Interventions

  • PROCEDURE ILIF

Study Locations (8)

South Carolina

  • Coastal Orthopaedic Associates PA - Conway
  • McLeod Regional Medical Center - Florence

Arizona

  • Desert Institute for Spine Care, Surgical Specialty Hospital of Arizona - Phoenix

California

  • The Spine Institute, St. John's Health Center - Santa Monica

Florida

  • North Florida Regional Medical Center - Gainesville

New Mexico

  • Lovelace Medical Center - Albuquerque

Texas

  • Center for Neurological Disorders, Texas Health Harris Methodist Fort Worth - Fort Worth

Virginia

  • Neurosurgical Specialists, DePaul Medical Center - Norfolk

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2009-11
Est. Completion 2014-06
NuVasive

28 total trials

What the finished NCT01019057 record still lists

NCT01019057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which ILIF is the first listed.

NCT01019057 lists 8 locations in 7 states (South Carolina, Arizona, California).

Frequently Asked Questions

What is clinical trial NCT01019057 about?

NCT01019057 is a clinical study titled "An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)". Patients diagnosed with single-level degenerative disc disease (DDD) of the lumbar spine undergo a posterior decompression followed by a fusion complete with a spinous process plate, graft, and a biologic.

What is the current status of trial NCT01019057?

This trial is currently completed. The enrollment target is 77 participants. The study started on 2009-11. Estimated completion is 2014-06.

What conditions does trial NCT01019057 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT01019057?

The interventions under investigation include: ILIF (PROCEDURE).

Who is sponsoring clinical trial NCT01019057?

This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01019057 being conducted?

This trial has 8 study locations across Arizona, California, Florida, New Mexico, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01019057's enrollment target sits among peer trials

77 25th of 42 higher than 18 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01019057, the US trial registry maintained by the National Library of Medicine. NCT01019057 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.